Overview Financials News + Filings Key Docs Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results
|
Gain Therapeutics, Inc.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/10/2023 |
8-K
| Quarterly results |
05/12/2023 |
8-K
| Quarterly results |
03/23/2023 |
8-K
| Quarterly results |
12/16/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
09/20/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs:
|
"Transition Agreement, by and between the Company and Eric Richman",
"AMENDED AND RESTATED EMPLOYMENT AGREEMENT This Amended and Restated Employment Agreement is effective as of , by and between Gain Therapeutics, Inc. and Matthias Alder . This Agreement amends, restates, and supersedes in its entirety the Employment Agreement between the Company and Executive entered into effective October 15, 2021 . WHEREAS, the Company desires to continue to retain the services of Executive, now in the role of Chief Executive Officer as further set forth in this Agreement; WHEREAS, the Company’s Board of Directors desires to appoint Executive as the Company’s President and Chief Executive Officer as further set forth in this Agreement, effective as of the Effective Date; and WHEREAS, Executive desires to serve the Company in such capacity, subject to the terms and conditi...",
"GAIN THERAPEUTICS Announces PROMOTION OF Matthias Alder TO chief executive officer" |
|
08/08/2022 |
8-K
| Quarterly results |
06/17/2022 |
8-K
| Quarterly results |
03/24/2022 |
8-K
| Quarterly results |
12/28/2021 |
8-K
| Quarterly results |
11/12/2021 |
8-K
| Quarterly results |
10/20/2021 |
8-K
| Quarterly results |
08/11/2021 |
8-K
| Quarterly results |
05/10/2021 |
8-K
| Quarterly results |
05/04/2021 |
8-K
| Quarterly results |
03/22/2021 |
8-K
| Quarterly results |
|
|